Professional Documents
Culture Documents
Systemic Steroids Corticosteroids
Systemic Steroids Corticosteroids
Systemic Steroids Corticosteroids
DermNet NZ
Facts about skin from the New Zealand Dermatological Society Incorporated.
Systemic steroids
Systemic steroids are also called corticosteroids, glucocorticoids or cortisones. They are synthetic derivatives of the natural steroid, cortisol, which is produced by the adrenal glands. They are called systemic if the steroids are taken by mouth or given by intramuscular injection. Topical (cortico)steroids are applied directly to the skin. Inhaled steroids are breathed in. Systemic steroids include prednisone, prednisolone, methylprednisolone, beclamethasone, betamethasone, dexamethasone, fludrocortisone, hydrocortisone and triamcinolone. Systemic steroids work in the same way as natural cortisol, and are prescribed for a large number of serious diseases. Skin conditions treated with steroids include blistering diseases such as pemphigus and pemphigoid, and severe forms of dermatitis.
5/16/12
Moon face
Easy bruising
Sk in thinning
Fragile sk in
Acne
Effects on body fat Redistribution of body fat results in moon face, buffalo hump and truncal obesity. Weight gain occurs in most patients on long-term steroids due to increased apetite and increased food intake. Effects on the eye Glaucoma (increased intraocular pressure) can be due to corticosteroid eye drops as well as systemic steroids; often there is a family history of the disease. Posterior subcapsular cataracts in both eyes develop slowly; children are more susceptible than adults. Swelling of eyelids and eye muscles resulting in bulging eyes (exophthalmos) is a rare side effect. Central serous chorioretinopathy describes swelling within the eye resulting in separation of the choroid
dermnetnz.org/treatments/systemic-steroids.html 2/5
5/16/12
from the retina. Vascular disease Atherosclerosis (hardening of the arteries) in patients on long-term steroids may lead to: Ischaemic heart disease: angina, heart attack (myocardial infarction), heart failure and atrial arrhythmias Stroke (cerebrovascular accident, CVA) and transient ischaemic attack (TIA) Increased all-cause mortality. The effects of systemic steroids on atherosclerotic vascular disease may be due to complex metabolic changes, including: Reduction in release of ACTH (adrenocorticotropic hormone) leading to elevated VLDL (very low density lipoprotein), LDL (low density lipoprotein) cholesterol and triglycerides, and lower HDL (high density lipoprotein) cholesterol Peripheral insulin resistance and hyperinsulinaemia Gastrointestinal tract Gastritis and peptic ulceration may be caused by corticosteroids. Those also taking anti-inflammatory medications are at significantly increased risk of bleeding and should take acid-lowering medication to prevent this (e.g., a protein pump inhibitor such as omeprazole). Systemic steroids may mask symptoms, so that patients sometimes first learn of gastrointestinal disease when observing bleeding or when they become very ill from a perforation of the gut. There is an increased risk of fatty liver (hepatic steatosis) on long-term steroids. Fluid balance Sodium and fluid retention cause leg swelling and weight increase, usually in those with underlying heart or kidney disease. Increased blood pressure is common, especially with higher doses of steroid (more than 10mg of prednis(ol)one daily). Potassium loss may occur, causing general weakness. Reproductive system Effects of continuous use of corticosteroids include: Irregular menstruation Lowered fertility in men and women Possible increased risk of cleft palate in offspring of women taking steroids in pregnancy Musculoskeletal system Osteoporosis (thinning of the bones) due to corticosteroids is common, particularly in smokers, postmenopausal women, the elderly, those who are underweight or immobile, and patients with diabetes or lung problems. Osteoporosis may result in fractures of the spine, ribs or hip joint with minimal trauma. These occur after the first year in 10-20% of patients treated with more than 7.5mg prednis(ol)one daily. It is estimated that up to 50% of patients on long term oral corticosteroids will develop bone fractures. Osteonecrosis (destruction of bones such as the hip) is an uncommon but serious risk of high doses of steroids. Muscle weakness (myopathy) often affects shoulders and thighs. Vertebral fractures are more common in patients on steroids, even in those with normal bone density. Steroids prescribed to children reduce growth, which may not catch up when the steroids are discontinued after a prolonged course. Nervous system Psychological effects include mood changes, increased energy, excitement and euphoria. Psychiatric symptoms are less common but include hypomania, psychosis, delirium, memory loss and depression, which may require assessment and treatment. Insomnia and sleep distrurbance is more likely with split doses and tends to be less severe if a single daily dose taken in the morning. Shakiness and tremor is more likely on higher doses. Headaches are common but serious raised intracranial pressure is rare.
dermnetnz.org/treatments/systemic-steroids.html 3/5
5/16/12
Metabolic effects During and after steroid treatment, the adrenal gland produces less of its own cortisol, resulting from hypopituitary-pituitary-adrenal (HPA) axis suppression. Steroids may result in higher blood sugar (glucose) levels in patients with diabetes mellitus. Transient or persistent diabetes can affect previously nondiabetic patients, especially with higher daily doses of steroids. This needs treatment. Immune response Glucocorticoids result in inhibition of innate and acquired immunity and affect T cells, B cells, phagocytes and cytokines. This makes them effective in controlling a wide range of inflammatory diseases but also leads to adverse events. Increased susceptibility to internal infections, especially when high doses are prescribed (e.g. tuberculosis). Raised white cell count, especially due to an increase in circulating neutrophils Reduced efficacy and increased risk of vaccines Live vaccines such as polio or MMR (measles, mumps, rubella) should not be given to patients on higher doses of steroid (>20mg prednis(ol)one daily). It is safe and advisable to have other routine immunisations such as annual influenza vaccination.
Prevention of osteoporosis
Specific measures to reduce the chance of steroid-induced osteoporosis should be considered for patients that have taken or are expected to take 10 mg or more of prednis(ol)one or prednisolone each day for a period of three months or longer. A DEXA bone scan measures bone density. Bone density gives an indication of the risk of fracture due to bone loss. Arrange to have a scan as you start systemic steroids, and it should be repeated every year or as recommended by your physician. Preventative treatment includes the following medications: Adequate dietary intake or calcium tablets up to a daily intake of 1200mg calcium per day Vitamin D in various forms including monthly cholecalciferol 50,000 units (1.25 mg) Oestrogen i.e. hormone replacement tablets in females that have had early menopause Bisphosphonates (alendronate, etidronate, zolidronic acid); these are prescribed for patients at especially high risk of fracture.
dermnetnz.org/treatments/systemic-steroids.html 4/5
5/16/12
Treatment is most effective when started at the same time as the steroids, as most bone loss occurs within the first few months. This is most important for people taking more than 7.5mg of prednis(ol)one (or the equivalent dose of another oral corticosteroid) for three months or longer. If you smoke, stop. Consume minimal alcohol. Take regular weight bearing exercise e.g. walking for 30 to 60 minutes each day.
DermNet does not provide an on-line consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice. C reated 1997. Last updated 03 Mar 2012 . 2012 NZDSI. You may copy for personal use only. Please refer to our disclaimer and copyright policy.
dermnetnz.org/treatments/systemic-steroids.html
5/5